{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for moricizine in Related Substance Name (approximate match)
Showing 1 - 3 of 3 results
Status:
US Previously Marketed
Source:
ETHMOZINE by SHIRE
(1990)
Source URL:
First approved in 1990
Source:
ETHMOZINE by SHIRE
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
Moricizine is an antiarrhythmic agent previously marketed as Ethmozine. It was used for prophylaxis and treatment of serious and life-threatening ventricular arrhythmias. In 2007 it was withdrawn and discontinued for commercial reasons. Moricizine can be administered intravenously but was more commonly provided as an oral formulation.
Status:
US Approved Rx
(2013)
First approved in 1958
Class:
MIXTURE
Status:
US Previously Marketed
Source:
ETHMOZINE by SHIRE
(1990)
Source URL:
First approved in 1990
Source:
ETHMOZINE by SHIRE
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
Moricizine is an antiarrhythmic agent previously marketed as Ethmozine. It was used for prophylaxis and treatment of serious and life-threatening ventricular arrhythmias. In 2007 it was withdrawn and discontinued for commercial reasons. Moricizine can be administered intravenously but was more commonly provided as an oral formulation.
